{
    "organizations": [],
    "uuid": "60d6e4a83edbfa9c82634d21e53d6c33cff537ec",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-avadel-pharmaceuticals-announces-p/brief-avadel-pharmaceuticals-announces-pricing-of-125-mln-4-50-pct-exchangeable-senior-notes-idUSASB0C5O9",
    "ord_in_thread": 0,
    "title": "BRIEF-Avadel Pharmaceuticals Announces Pricing Of $125 Mln 4.50 Pct Exchangeable Senior Notes",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Avadel Pharmaceuticals Plc:\n* AVADEL PHARMACEUTICALS ANNOUNCES PRICING OF $125.0 MILLION 4.50% EXCHANGEABLE SENIOR NOTES DUE 2023\n* AVADEL PHARMACEUTICALS - 2023 NOTES WILL BE EXCHANGEABLE AT OPTION OF HOLDERS AT INITIAL EXCHANGE RATE OF 92.6956 ADSS/$1,000 PRINCIPAL AMOUNT OF NOTES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-14T21:31:00.000+02:00",
    "crawled": "2018-02-15T20:25:02.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "avadel",
        "pharmaceutical",
        "plc",
        "avadel",
        "pharmaceutical",
        "announces",
        "pricing",
        "million",
        "exchangeable",
        "senior",
        "note",
        "due",
        "avadel",
        "pharmaceutical",
        "note",
        "exchangeable",
        "option",
        "holder",
        "initial",
        "exchange",
        "rate",
        "principal",
        "amount",
        "note",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}